News & Updates

Show Multimedia Only

TDM offers benefits in thiopurine-treated children with leukaemia, IBD

29 Jan 2024

Therapeutic drug monitoring (TDM) helps identify children treated by thiopurine for acute lymphoblastic leukaemia (ALL) and inflammatory bowel disease (IBD) who have not reached their target levels or are over treated, reports a recent study.

TDM offers benefits in thiopurine-treated children with leukaemia, IBD

29 Jan 2024

AI improves adenoma detection during colonoscopy

29 Jan 2024 by

Compared with other endoscopic interventions such as high-definition (HD) colonoscopy, artificial intelligence (AI) has exhibited markedly better adenoma detection rate (ADR), as shown by the results of a systematic review and meta-analysis.

AI improves adenoma detection during colonoscopy

29 Jan 2024

$Durable responses seen with axatilimab in recurrent/refractory GVHD$

Durable responses seen with axatilimab in recurrent/refractory GVHD

29 Jan 2024 by

The anti–CSF-R1 antibody axatilimab offers rapid and durable responses in patients with recurrent/refractory chronic graft-versus-host disease (GVHD) in the pivotal phase II AGAVE-201 trial.

Durable responses seen with axatilimab in recurrent/refractory GVHD

29 Jan 2024

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

27 Jan 2024

Combining the programmed cell death ligand 1 (PDL-1) inhibitor avelumab with paclitaxel plus ramucirumab appears to be efficacious and safe in the second-line treatment of metastatic esophagogastric adenocarcinoma, as shown in the phase II nonrandomized RAP trial.

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

27 Jan 2024

Cetuximab stored in vials, bags for days remains stable

25 Jan 2024 by

A recent study has demonstrated the extended physicochemical stability of cetuximab in opened vials and infusion bags, which can help save costs for healthcare providers.

Cetuximab stored in vials, bags for days remains stable

25 Jan 2024

PRS enhances ultrasound-based assessment of thyroid nodules

24 Jan 2024

A recent study suggests that an ultrasound-based classification of thyroid nodules as either benign or malignant can improve its diagnostic accuracy by combining it with polygenic risk scores (PRS).

PRS enhances ultrasound-based assessment of thyroid nodules

24 Jan 2024

Delayed postoperative radiation tied to higher recurrence, death in MCC

23 Jan 2024

Delays in postoperative radiation therapy (PORT) may lead to increased locoregional recurrence (LRR), usually occurring beyond the radiation field, among patients with Merkel cell carcinoma (MCC), as shown in a recent study.

Delayed postoperative radiation tied to higher recurrence, death in MCC

23 Jan 2024

Adding bevacizumab to chemo enhances antitumour activity in children with R/R neuroblastoma

23 Jan 2024 by

Adding bevacizumab (B) to temozolomide (T)-based chemotherapy increases overall response rate (ORR) in children with relapsed/refractory (R/R) neuroblastoma, according to results of the three-by-two factorial, randomized controlled phase II BEACON-Neuroblastoma trial.

Adding bevacizumab to chemo enhances antitumour activity in children with R/R neuroblastoma

23 Jan 2024

The 100,000 Genomes Project: Insights from the cancer programme

22 Jan 2024 by

Recently published data from the cancer programme of the 100,000 Genomes Project, which maps out the genomic patterns of patients with different cancer types using whole-genome sequencing (WGS), have provided insights on integrating genomics into routine cancer care.

The 100,000 Genomes Project: Insights from the cancer programme

22 Jan 2024

Cancer survivors may benefit from social media-based interventions

22 Jan 2024 by

A meta-analysis and meta-regression of randomized controlled trials (RCTs) found that social media-based interventions – which are interventions from any form of online medium that enables participant interaction (eg, Facebook, Instagram, TikTok, Twitter) – may be beneficial for cancer patients.

Cancer survivors may benefit from social media-based interventions

22 Jan 2024

News & Updates

Filter by Specialty:

Specialty:

TDM offers benefits in thiopurine-treated children with leukaemia, IBD

TDM offers benefits in thiopurine-treated children with leukaemia, IBD

AI improves adenoma detection during colonoscopy

AI improves adenoma detection during colonoscopy

Durable responses seen with axatilimab in recurrent/refractory GVHD

Durable responses seen with axatilimab in recurrent/refractory GVHD

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

Avelumab with paclitaxel plus ramucirumab shows promise in esophagogastric adenocarcinoma

Cetuximab stored in vials, bags for days remains stable

Cetuximab stored in vials, bags for days remains stable

PRS enhances ultrasound-based assessment of thyroid nodules

PRS enhances ultrasound-based assessment of thyroid nodules

Delayed postoperative radiation tied to higher recurrence, death in MCC

Delayed postoperative radiation tied to higher recurrence, death in MCC

Adding bevacizumab to chemo enhances antitumour activity in children with R/R neuroblastoma

Adding bevacizumab to chemo enhances antitumour activity in children with R/R neuroblastoma

The 100,000 Genomes Project: Insights from the cancer programme

The 100,000 Genomes Project: Insights from the cancer programme

Cancer survivors may benefit from social media-based interventions

Cancer survivors may benefit from social media-based interventions